13911
|
|
|
DNA topoisomerase II binding protein 1 |
Dpb11, TOP2BP1 |
|
13912
|
|
|
TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase |
LUN, P53BP3, RP31, TP53BPL |
Choroideremia, Ciliopathy, Hyperopia, Macular degeneration, Macular dystrophy, Metabolic syndrome, Optic atrophy, Orofaciodigital syndrome, Osteosarcoma, Retinitis pigmentosa, Diabetes mellitus type 2 |
13913
|
|
|
Torsin family 1 member A |
AMC5, DQ2, DYT1 |
|
13914
|
|
|
Torsin 1A interacting protein 1 |
LAP1, LAP1B, LAP1C, LGMD2Y |
|
13915
|
|
|
Torsin 1A interacting protein 2 |
IFRG15, LULL1, NET9 |
|
13916
|
|
|
Torsin family 1 member B |
DQ1 |
|
13917
|
|
|
Torsin family 4 member A |
C9orf167 |
|
13918
|
|
|
Thymocyte selection associated high mobility group box |
TOX1 |
Attention deficit hyperactivity disorder, Cannabis abuse, Colorectal cancer, Essential tremor, Inflammatory bowel disease, Insomnia, Iron-refractory iron deficiency anemia, Major depressive disorder, Schizophrenia, Scoliosis, Substance abuse, Diabetes mellitus type 1, Diabetes mellitus type 2 |
13919
|
|
|
TOX high mobility group box family member 2 |
C20orf100, GCX-1, GCX1, dJ1108D11.2, dJ495O3.1 |
|
13920
|
|
|
TOX high mobility group box family member 3 |
CAGF9, TNRC9 |
Biliary tract cancer, Breast cancer, Breast neoplasms, Male breast neoplasms, Cancer, Cervical cancer, Colorectal cancer, Congenital esophageal anomaly, Endometrial cancer, Esophageal cancer, Estrogen-receptor negative breast cancer, Gastric cancer, Hepatocellular carcinoma, Insomnia, Liver neoplasms, Lung cancer, Metabolic syndrome, Neurotic disorder, Non-hodgkins lymphoma, Ovarian cancer, Ovarian serous carcinoma, Pancreatic cancer, Polycystic ovary syndrome, Prostate cancer, Willis-ekbom disease, Squamous cell carcinoma, Diabetes mellitus type 2View all (12 more) |